Ross Benjamin P, Braddy April C, McGeary Ross P, Blanchfield Joanne T, Prokai Laszlo, Toth Istvan
School of Molecular and Microbial Sciences and School of Pharmacy, University of Queensland, Brisbane, Queensland 4072, Australia.
Mol Pharm. 2004 May-Jun;1(3):233-45. doi: 10.1021/mp049964d.
The co-administration of a drug with a penetration enhancer (PE) is one method by which the membrane permeability of a drug can be improved. To facilitate PE design, it is important that the molecular basis of PE toxicity and efficacy be examined, so we investigated the membrane affinity and micellar aggregation of a series of synthetic liposaccharide PEs and correlated these properties with hemolytic potency. The influence of liposaccharide alkyl chain length (nc) on the system was studied, and comparisons were made with conventional PEs such as bile salts, fatty acids, and surfactants. The liposaccharides were each synthesized in eight steps in good overall yield. Their critical micelle concentrations (CMCs) in phosphate-buffered saline ranged from 0.207 to 20.2 mM, and it was found that increasing nc by 2 afforded a 1 order of magnitude decrease in the CMC. Immobilized artificial membrane (IAM) chromatography was used to determine each PE's affinity for biological membranes, and an increase in nc caused a significant increase in the extent of membrane binding. A study of hemolytic activity revealed that liposaccharides with an nc of < or = 12 are the most likely to be biocompatible. The CMC values for all PEs showed a negative correlation with hemolytic potency; however, it was PE monomers, not micelles, that were responsible for the onset of hemolysis. The affinity of all enhancers for the IAM displayed a positive correlation with hemolytic potency, and therefore, IAM chromatography can be used to predict PE hemolytic activity. It was concluded that the biocompatibility of liposaccharides can be modulated by minor alterations in nc.
将药物与渗透促进剂(PE)共同给药是一种可以提高药物膜通透性的方法。为了便于设计渗透促进剂,研究其毒性和功效的分子基础很重要,因此我们研究了一系列合成脂糖渗透促进剂的膜亲和力和胶束聚集情况,并将这些性质与溶血效力相关联。研究了脂糖烷基链长度(nc)对该体系的影响,并与胆盐、脂肪酸和表面活性剂等传统渗透促进剂进行了比较。每种脂糖均通过八步合成,总产率良好。它们在磷酸盐缓冲盐溶液中的临界胶束浓度(CMC)范围为0.207至20.2 mM,发现nc增加2会使CMC降低1个数量级。使用固定化人工膜(IAM)色谱法测定每种渗透促进剂对生物膜的亲和力,nc的增加导致膜结合程度显著增加。溶血活性研究表明,nc≤12的脂糖最有可能具有生物相容性。所有渗透促进剂的CMC值与溶血效力呈负相关;然而,导致溶血发生的是渗透促进剂单体,而非胶束。所有增强剂对IAM的亲和力与溶血效力呈正相关,因此,IAM色谱法可用于预测渗透促进剂的溶血活性。得出的结论是,通过对nc进行微小改变可以调节脂糖的生物相容性。